Abstract:Objective To explore the effect of different doses of vitamin D (VitD) and calcium supplementation on blood glucose and insulin sensitivity in middle?aged and elderly patients with impaired glucose tolerance (IGT). Methods A total of 150 individuals with IGT [aged (57 ± 4) years] were chosen during physical examination from January 2013 to May 2015, of which 80 cases were male and 70 were female. They were randomly divided into three groups:regular dose group (group A, n=49, VitD 125 U/d+calcium 600 mg/d), double dose group (group B, n=51, VitD 250 U/d + calcium 1 200 mg/d), and control group (group C, n=50, no medication). Oral glucose tolerance test (OGTT) was performed before and after VitD and calcium supplementation. Blood biochemical parameters were measured. Homeostasis model assessment (HOMA) insulin resistance index (HOMA?IR) and HOMA isletβ?cell function index (HOMA?β) were calculated. Comparison of means was done by one?way analysis of variance (ANOVA). LSD?t test was used when P<0.05 as the limit for statistical significance.appropriate. Correlation analysis was performed using Pearson correlation analysis and multiple stepwise regression analysis. Results (1) Compared with group C, fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG) and insulin (2hINS), glycated hemoglobin A1c (HbA1c), HOMA?IR in group A and B declined significantly (P<0.05) after 6 and 12 months of VitD and calcium treatment, while the level of serum 25(OH)D and HOMA?βwere dramatically increased (all P<0.05). (2) After 6 and 12 months treatment, HbA1c, HOMA?IR significantly declined from baseline [HbA1c:(5.9 ± 0.5)%,(5.9 ± 0.6)%;HOMA?IR:(3.8 ± 0.9, 3.7 ± 0.7)] in group A [HbA1c:(5.7 ± 0.2)%,(5.6 ± 0.6)%;HOMA?IR:3.6±1.1, 3.4±1.5] and group B [HbA1c:(5.7±0.6)%,(5.5±0.4)%;HOMA?IR:2.8±1.5 vs 2.0±1.2] (all P<0.05). And the levels of FPG and 2hPG were also reduced. The differences were significantly (all P<0.05). (3) In addition, FINS, 2hINS, HbA1c and HOMA?IR in 12 months after treatment were declined in group B compared with group A, while the level of serum 25(OH)D in group B was increased [(40 ± 5)vs (32 ± 6)μg/L] ( all P<0.05).(4) Pearson correlation coefficient analysis showed that serum 25(OH)D in 12 months post?treatment was positively correlated with HOMA?β(r=0.210), serum calcium (r=0.444) (both P<0.05); while was negatively correlated with HbA1c (r=-0.241), FPG (r=-0.215) and HOMA?IR (r=-0.225) (P<0.05). Multiple regression analysis indicated that serum 25(OH)D in patients with IGT was markedly positively correlated with HbA1c (r=2.138) VitD doses (r=7.160 for regular?dose, 7.330 for double dose) and total cholesterol (r=2.319) (P<0.05). Conclusion Vitamin D and calcium supplementation can improve blood glucose and insulin sensitivity in middle?aged and elderly patients with IGT, in a dose and time dependent manner.

Effects of different doses of Caltrate D supplementation on insulin resistance in patients with impaired glucose tolerance and vitamin D deficiency

Effect of Different Doses Vitamin D and Calcium Supplementation on Blood Glucose and Insulin Sensitivity in Middle-Aged and Elderly Patients with Impaired Glucose Tolerance

[Effects of Vitamin D Supplementation on Insulin Resistance in Patients with Type 2 Diabetes Mellitus].

Ultra-high-performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Serum Metabolomic Characteristics in People with Different Vitamin D Levels

Effect of vitamin D intervention on the outcome of glucose metabolism in patients with impaired glucose regulation

Combined Chromium and Magnesium Decreases Insulin Resistance More Effectively Than Either Alone.

Effects of Active Vitamin D on Insulin Resistance and Islet Β-Cell Function in Non-Diabetic Chronic Kidney Disease Patients: a Randomized Controlled Study

Effects of Vitamin D3 Supplementation Combined with Standardized Hypoglycemic Regimen on Islet Β Cell Function and Macrovascular Complications in Newly Diagnosed Type 2 Diabetes Mellitus

Effects of calcium and vitamin D supplementation on glycaemic control and markers of inflammation in diabetes mellitus and high-risk groups:a Meta-analysis of randomized controlled trials

Effects of vitamin D supplementation on glucose and lipid metabolism in patients with type 2 diabetes mellitus and risk factors for insulin resistance

Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study

The changes of serum Vitamin D level in people with different glucose tolerance

Effect of Various Doses of Vitamin D Supplementation on Pregnant Women with Gestational Diabetes Mellitus: A Randomized Controlled Trial.

The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial

Combined effects of vitamin D supplementation and endurance exercise training on insulin resistance in newly diagnosed type 2 diabetes mellitus patients with vitamin D deficiency: study protocol for a randomized controlled trial

Comparison of the Effects of Cholecalciferol and Calcitriol on Calcium Metabolism and Bone Turnover in Chinese Postmenopausal Women with Vitamin D Insufficiency

Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial

Vitamin D Supplementation Reduces Insulin Resistance in Japanese Adults: a Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial

The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis

The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)

Effect of Vitamin D Supplementation on Glycemic Control in Newly Diagnosed Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial